Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 3
2002 1
2003 10
2004 10
2005 12
2006 3
2007 24
2008 19
2009 20
2010 23
2011 25
2012 30
2013 24
2014 30
2015 27
2016 38
2017 39
2018 38
2019 39
2020 38
2021 36
2022 21
2023 21

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Results by year

Filters applied: . Clear all
Page 1
PCSK9 inhibitors and cardiovascular outcomes.
Steffens D, Bramlage P, Scheeff C, Kasner M, Hassanein A, Friebel J, Rauch-Kröhnert U. Steffens D, et al. Among authors: bramlage p. Expert Opin Biol Ther. 2020 Jan;20(1):35-47. doi: 10.1080/14712598.2020.1677604. Epub 2019 Oct 18. Expert Opin Biol Ther. 2020. PMID: 31593483
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial.
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Nöh L, Schiffer M, Uder M, Achenbach S, Schmieder RE. Kolwelter J, et al. Among authors: bramlage p. Clin Res Cardiol. 2023 Jan;112(1):134-144. doi: 10.1007/s00392-022-02119-7. Epub 2022 Oct 26. Clin Res Cardiol. 2023. PMID: 36289063 Free PMC article. Clinical Trial.
Factor Xa inhibition.
Bramlage P, Pittrow D, Kirch W. Bramlage P, et al. Eur J Clin Invest. 2005 Mar;35 Suppl 1:1-3. doi: 10.1111/j.0960-135X.2005.01450.x. Eur J Clin Invest. 2005. PMID: 15701141 No abstract available.
[Perioperative management of anticoagulation].
Eisele R, Melzer N, Bramlage P. Eisele R, et al. Among authors: bramlage p. Chirurg. 2014 Jun;85(6):513-9. doi: 10.1007/s00104-014-2738-6. Chirurg. 2014. PMID: 24823997 Review. German.
Angiotensin-converting enzyme inhibitors stimulate cerebral arteriogenesis.
Hillmeister P, Nagorka S, Gatzke N, Dülsner A, Li K, Dai M, Bondke Persson A, Lauxmann MA, Jaurigue J, Ritter O, Bramlage P, Buschmann E, Buschmann I. Hillmeister P, et al. Among authors: bramlage p. Acta Physiol (Oxf). 2022 Feb;234(2):e13732. doi: 10.1111/apha.13732. Epub 2021 Oct 2. Acta Physiol (Oxf). 2022. PMID: 34555240
U300, a novel long-acting insulin formulation.
Sutton G, Minguet J, Ferrero C, Bramlage P. Sutton G, et al. Among authors: bramlage p. Expert Opin Biol Ther. 2014 Dec;14(12):1849-60. doi: 10.1517/14712598.2014.970633. Epub 2014 Oct 14. Expert Opin Biol Ther. 2014. PMID: 25311556 Review.
Nitroglycerin application and coronary arteriogenesis.
Gatzke N, Hillmeister P, Dülsner A, Güc N, Dawid R, Smith KH, Pagonas N, Bramlage P, Gorath M, Buschmann IR. Gatzke N, et al. Among authors: bramlage p. PLoS One. 2018 Aug 17;13(8):e0201597. doi: 10.1371/journal.pone.0201597. eCollection 2018. PLoS One. 2018. PMID: 30118486 Free PMC article.
Betrixaban - the next direct factor Xa inhibitor?
Thoenes M, Minguet J, Bramlage K, Bramlage P, Ferrero C. Thoenes M, et al. Among authors: bramlage p. Expert Rev Hematol. 2016 Dec;9(12):1111-1117. doi: 10.1080/17474086.2016.1256194. Epub 2016 Nov 17. Expert Rev Hematol. 2016. PMID: 27809616 Review.
469 results